Shaanxi, China

Bingxing Zhang


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Bingxing Zhang

Introduction

Bingxing Zhang is a prominent inventor based in Shaanxi, China. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative research and development of new compounds. His work focuses on enhancing the efficacy and solubility of antibacterial agents.

Latest Patents

Bingxing Zhang holds a patent for a "Pleuromutilin derivative containing a thiazolo[5,4-c]pyridine side chain, and a preparation method and application thereof." This patent describes a compound of formula I, which includes a pharmaceutically acceptable salt or a solvent compound, as well as its enantiomers, diastereomers, or tautomers. The invention addresses the issue of poor solubility associated with pleuromutilin derivatives while demonstrating good in vitro antibacterial activity.

Career Highlights

Bingxing Zhang is affiliated with the Shaanxi University of Science and Technology, where he conducts research and teaches. His work has led to advancements in the pharmaceutical industry, particularly in the development of new antibacterial agents. His innovative approach has garnered attention and respect within the scientific community.

Collaborations

Bingxing Zhang collaborates with notable colleagues, including Chengyuan Liang and Yanzi Wang. These partnerships enhance the research efforts and contribute to the successful development of new pharmaceutical compounds.

Conclusion

Bingxing Zhang's contributions to the field of pharmaceuticals through his innovative research and patent on pleuromutilin derivatives highlight his role as a significant inventor. His work not only addresses critical challenges in drug solubility but also paves the way for future advancements in antibacterial treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…